?Mifepristone API?
?? USP/EP 98% Purity | Medical Abortion & Cushing’s Syndrome Treatment | cGMP Certified

?Product Overview?

Mifepristone is a ?high-purity active pharmaceutical ingredient (API)? primarily used for ?medical abortion? and ?endocrine disorder management?. As a ?progesterone receptor antagonist?, it effectively blocks hormonal activity, making it critical in ?reproductive healthcare? and ?Cushing’s syndrome therapy?. Compliant with ?USP/EP standards?, it is widely utilized in ?pharmaceutical formulations? for human therapeutics.

?Key Benefits?

? ?98% USP/EP-Grade Purity?

• Meets stringent pharmacopeial guidelines with ?HPLC/GC-MS testing? (impurities ≤0.2%).

? ?Rapid Therapeutic Action?

• Achieves peak efficacy within ?24–48 hours? for pregnancy termination.

? ?Stability & Versatility?

• Compatible with ?oral tablets? and ?controlled-release formulations? (pH 6.0–8.0).

?Applications?

      ?? ?Reproductive Health?

• Medical abortion protocols (combined with misoprostol).

• ?? ?Endocrine Disorders?

• Management of Cushing’s syndrome and hormone-dependent tumors.

?Quality Certifications?

?? ?USP/EP Monograph Compliance?

• Produced in ?FDA/EMA-approved facilities? with ISO 9001:2025 accreditation.

?? ?cGMP Manufacturing?

• Rigorous stability testing ensures shelf life of ?≥24 months?.

• 
  

?Market Trends?

?? ?Growing Clinical Demand?

• Projected ?9% CAGR growth? (2023–2030) driven by rising access to reproductive healthcare.

?? ?Research Validation?

• Cited in ?20+ clinical trials? for efficacy in endocrine and gynecological therapies.